The Cardiovascular Disease Drug market was valued at USD 155.60 Million in 2021 and is expected to reach USD 230.24 Million by 2029, growing at a CAGR of 5.02% (2022-2029). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.